1. Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retrovir. 2011;27(7):751–8.

2. Crawford TN, Thornton A. Retention in continuous care and sustained viral suppression: examining the association among individuals living with HIV. J Int Assoc Provid AIDS Care (JIAPAC). 2017;16(1):42–7.

3. Philbin MM, Feaster DJ, Gooden L, Duan R, Das M, Jacobs P, et al. The north-south divide: substance use risk, care engagement, and viral suppression among hospitalized HIV-infected patients in 11 US cities. Clin Infect Dis. 2018;68(1):146–9.

4. Crawford TN. Poor retention in care one-year after viral suppression: a significant predictor of viral rebound. AIDS Care. 2014;26(11):1393–9.

5. CDC. HIV in the Southern United States. https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf: CDC; 2016.

6. Udeagu C-CN, Webster TR, Bocour A, Michel P, Shepard CW. Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS 2013;27(14):2271–9.

7. Dombrowski JC, Bove J, Roscoe JC, Harvill J, Firth CL, Khormooji S, et al. "Out of Care" HIV case investigations: a collaborative analysis across 6 states in the northwest US. J Acquir Immun Defic Syndr. (1999). 2017;74(Suppl 2): S81–S7.

8. Seña AC, Donovan J, Swygard H, Clymore J, Mobley V, Sullivan K, et al. The North Carolina HIV bridge counselor program: outcomes from a statewide level intervention to link and reengage HIV-infected persons in care in the South. JAIDS J Acquir Immun Defic Syndr. 2017;76(1):e7–e14.

9. Buchacz K, Chen M-J, Parisi MK, Yoshida-Cervantes M, Antunez E, Delgado V, et al. Using HIV surveillance registry data to re-link persons to care: the RSVP Project in San Francisco. PLoS ONE. 2015;10(3):e0118923.

10. Wohl AR, Dierst-Davies R, Victoroff A, James S, Bendetson J, Bailey J, et al. Implementation and operational research: the navigation program an intervention to reengage lost patients at 7 HIV clinics in Los Angeles County, 2012–2014. JAIDS J Acquir Immun Defic Syndr. 2016;71(2):e44–e50.

11. Bove J, Golden MR, Dhanireddy S, Harrington RD, Dombrowski JC. Outcomes of a clinic-based, surveillance-informed intervention to relink patients to HIV care. J Acquir Immun Defic Syndr. (1999). 2015;70(3):262.

12. Yehia BR, Rebeiro P, Althoff KN, Agwu AL, Horberg MA, Samji H, et al. The impact of age on retention in care and viral suppression. J Acquir Immun Defic Syndr (1999). 2015;68(4):413.

13. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials. 2009;10(5):299–305.

14. Westergaard RP, Hess T, Astemborski J, Mehta SH, Kirk GD. Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS (London, England). 2013;27(16):2559.

15. Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5–e16.

16. Westergaard RP, Spaulding AC, Flanigan TP. HIV among persons incarcerated in the US: a review of evolving concepts in testing, treatment and linkage to community care. Curr Opin infect Dis. 2013;26(1):10.

17. Montague BT, Rosen DL, Solomon L, Nunn A, Green T, Costa M, et al. Tracking linkage to HIV care for former prisoners. Virulence. 2012;3(3):319–24.

18. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.

19. Draine J, Ahuja D, Altice FL, Arriola KJ, Avery AK, Beckwith CG, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011;23(3):366–77.

20. Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.

21. Avery AK, Ciomcia RW, Lincoln T, Desbrais M, Jordan AO, Rana AI, et al. Jails as an opportunity to increase engagement in HIV care: findings from an observational cross-sectional study. AIDS Behav. 2013;17(2):137–44.

22. Skarbinski J, Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the united states. JAMA Intern Med. 2015;175(4):588–96.

23. Haley DF, Golin CE, Farel CE, Wohl DA, Scheyett AM, Garrett JJ, et al. Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners’ perspectives before and after community reentry. BMC Public Health. 2014;14(1):1253.

24. Wakeman SE, McKinney ME, Rich JD. Filling the gap: the importance of Medicaid continuity for former inmates. J Gen Intern Med. 2009;24(7):860–2.

25. Cuellar AE, Cheema J. As roughly 700,000 prisoners are released annually, about half will gain health coverage and care under federal laws. Health Aff. 2012;31(5):931–8.

26. Sidibe T, Golin C, Turner K, Fray N, Fogel C, Flynn P, et al. Provider perspectives regarding the health care needs of a key population: HIV-infected prisoners after incarceration. J Assoc Nurses in AIDS Care. 2015;26(5):556–69.

27. Harding DJ, Morenoff JD, Herbert CW. Home is hard to find: Neighborhoods, institutions, and the residential trajectories of returning prisoners. Ann Am Acad Polit Social Sci. 2013;647(1):214–36.

28. Harding DJ, Wyse JJ, Dobson C, Morenoff JD. Making ends meet after prison. J Policy Anal Manag. 2014;33(2):440–70.

29. Cropsey KL, Binswanger IA, Clark CB, Taxman FS. The unmet medical needs of correctional populations in the United States. J Nat Med Assoc. 2012;104(11):487–92.

30. Baillargeon JG, Giordano TP, Harzke AJ, Baillargeon G, Rich JD, Paar DP. Enrollment in outpatient care among newly released prison inmates with hiv infection. Pub Health Rep. 2010;125(Suppl 1):64–71.

31. Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301(8):848–57.

32. Nijhawan AE, Liang Y, Vysyaraju K, Muñoz J, Ketchum N, Saber J, et al. Missed initial medical visits: predictors, timing, and implications for retention in HIV care. AIDS Patient Care STDs. 2017;31(5):213–21.

33. Ford N, Migone C, Calmy A, Kerschberger B, Kanters S, Nsanzimana S, et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS (London, England). 2018;32(1):17.

34. Colasanti J, Sumitani J, Mehta CC, Zhang Y, Nguyen ML, del Rio C, et al., editors. Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the Southern United States: open forum infectious diseases; US: Oxford University Press; 2018.

35. Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, et al. The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting. J Acquir Immun Defic Syndr. (1999) 2017;74(1):44–51.

36. Steadman HJ, Osher FC, Robbins PC, Case B, Samuels S. Prevalence of serious mental illness among jail inmates. Psychiatr Serv. 2009;60(6):761–5.

37. Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7(1):3.

38. Baillargeon J, Binswanger IA, Penn JV, Williams BA, Murray OJ. Psychiatric disorders and repeat incarcerations: the revolving prison door. Am J Psychiatr. 2009;166(1):103–9.

39. State Mental Health Agency (SMHA) Per capita mental health services expenditures [Internet]. [cited Oct 30, 2018].

40. CJC TCJC. Recommendations for House Select Committe on opioids & substance use disorder. https://www.texascjc.org/system/files/publications/SUDC%20Recommendations%20for%20Interim%20Select%20Committee%20on%20Opioids%20%28Aug%202018%29.pdf; 2018 August 2018.

41. Booker CA, Flygare CT, Solomon L, Ball SW, Pustell MR, Bazerman LB, et al. Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release. AIDS Behav. 2013;17(2):128–36.

42. Spaulding AC, Messina LC, Kim BI, Chung K-W, Lincoln T, Teixeira P, et al. Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. AIDS Behav. 2013;17(2):203–11.

43. Wohl DA, Scheyett A, Golin CE, White B, Matuszewski J, Bowling M, et al. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav. 2011;15(2):356–64.

44. Spaulding AC, Seals RM, McCallum VA, Perez SD, Brzozowski AK, Steenland NK. Prisoner survival inside and outside of the institution: implications for health-care planning. Am J Epidemiol. 2011;173(5):479–87.

45. Khawcharoenporn T, Zawitz C, Young JD, Kessler HA. Continuity of care in a cohort of HIV-infected former jail detainees. J Correct Health Care. 2013;19(1):36–42.

46. Montague BT, Rosen DL, Sammartino C, Costa M, Gutman R, Solomon L, et al. Systematic assessment of linkage to care for persons with HIV released from corrections facilities using existing datasets. AIDS Patient Care STDs. 2016;30(2):84–91.

47. Fuller SM, Koester KA, Maiorana A, Steward WT, Broaddus MR, Lass K, et al. “I don’t have to do this all by myself”: systems navigation to ensure continuity of HIV care for persons leaving prison. AIDS Behav. 2019;23(1):14–24.

48. Ulett KB, Willig JH, Lin H-Y, Routman JS, Abroms S, Allison J, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDs. 2009;23:41–9.

49. Crepaz N, Tang T, Marks G, Mugavero MJ, Espinoza L, Hall HI. Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012–2013. Clin Infect Dis. 2016;63(7):976–83.

50. Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-related disparities in criminal justice and HIV treatment outcomes: a retrospective cohort study of HIV-infected inmates. Am J Public Health. 2015;105(9):1901–10.

51. Baillargeon J, Giordano TP, Harzke AJ, Spaulding AC, Wu ZH, Grady JJ, et al. Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDs. 2010;24(6):389–94.

52. Loeliger KB, Meyer JP, Desai MM, Ciarleglio MM, Gallagher C, Altice FL. Retention in HIV care during the 3 years following release from incarceration: a cohort study. PLoS Med. 2018;15(10):e1002667.

53. Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592–600.